Your browser doesn't support javascript.
loading
The in vitro activity of delafloxacin and comparator agents against bacterial pathogens isolated from patients with cancer.
Gerges, Bahgat; Rolston, Kenneth; Shelburne, Samuel A; Rosenblatt, Joel; Prince, Randall; Raad, Issam.
Affiliation
  • Gerges B; Department of Infectious Diseases, Infection Control and Employee Health Research, The University of Texas MD Anderson Cancer Center, 1515 Holcomb Blvd, Houston, TX 77030, USA.
  • Rolston K; Department of Infectious Diseases, Infection Control and Employee Health Research, The University of Texas MD Anderson Cancer Center, 1515 Holcomb Blvd, Houston, TX 77030, USA.
  • Shelburne SA; Department of Infectious Diseases, Infection Control and Employee Health Research, The University of Texas MD Anderson Cancer Center, 1515 Holcomb Blvd, Houston, TX 77030, USA.
  • Rosenblatt J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcomb Blvd, Houston, TX 77030, USA.
  • Prince R; Department of Infectious Diseases, Infection Control and Employee Health Research, The University of Texas MD Anderson Cancer Center, 1515 Holcomb Blvd, Houston, TX 77030, USA.
  • Raad I; Department of Infectious Diseases, Infection Control and Employee Health Research, The University of Texas MD Anderson Cancer Center, 1515 Holcomb Blvd, Houston, TX 77030, USA.
JAC Antimicrob Resist ; 5(2): dlad034, 2023 Apr.
Article de En | MEDLINE | ID: mdl-36994231

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: JAC Antimicrob Resist Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: JAC Antimicrob Resist Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni